Shulgin, AT; Jacob, P. Potential misrepresentation of 3,4-methylene-dioxyamphetamine (MDA). A toxicological warning. J. Anal. Toxicol., 1 Jan 1982, 6 (2), 71–75. 5.6 MB. https://doi.org/10.1093/jat/6.2.71 #5 GC,MS,IR
Aldous, FAB; Barrass, BC; Brewster, K; Buxton, DA; Green, DM; Pinder, RM; Rich, P; Skeels, PM; Tutt, KJ. Structure-activity relationships in psychotomimetic phenylalkylamines. J. Med. Chem., 1 Oct 1974, 17 (10), 1100–1111. 1.2 MB. https://doi.org/10.1021/jm00256a016 #22 other
Sanuki, K; Orui, H; Fujii, T; Kurashima, N; Ikehara, Y. Synthesis and analysis of phenethylamine analogues. JCCL, 1 Nov 2007, (47), 33–39. 2.0 MB. #HMDA Japanese, English abstract LC,MS,NMR,IR,UV,other
ADAM · EA-1475 · MDM · MDMA · X · XTC
3,4-(Methylmethylenedioxy)amphetamine · 7-Me-MDA · EIDA
4-MeOMC · Methedrone · PM-MCAT · PMMA-βk · PMMC · bk-PMMA
2-Me-4,5-MDA · 6-Me-MDA · 6-Methyl-MDA
2,3-MDPH · α,α-Me-2,3-MDPEA
N-Ethyl-N-methylpiperonylamine
4-Carboxymethamphetamine · 4-HOOC-MA
4-Aminomethyl-6-methoxychromane
8-Hydroxy-7-methoxy-1-methyl-THIQ · Arizonine
8-Hydroxy-7-methoxy-2-methyl-THIQ
7-Hydroxy-8-methoxy-2-methyl-THIQ
6-Hydroxy-7-methoxy-2-methyl-THIQ · Isocorypalline